Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System
07 sept. 2022 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...